Catalent - Navigating Early Drug Development Journey: Strategies for Successful Phase 1 Supported by Bionow

Catalent - Navigating Early Drug Development Journey: Strategies for Successful Phase 1 Supported by Bionow

DoubleTree by Hilton, Nottingham
Thursday 18th April

Event Logo


Join Catalent & Bionow in-person to explore latest strategies in bioavailability enhancement, clinical trial planning, and manufacturing for clinical success.

Small and mid-size pharmaceutical companies that have early drug development assets face unique challenges in bringing new drugs to the market. These challenges include overcoming formulation issues related to poorly soluble and permeable drugs, streamlining manufacturing processes for clinical trials, and expediting progression through clinical trials to achieve milestones critical for continued funding and investment.

This event aims to provide attendees with access to the latest advances in formulation techniques, clinical trial planning and manufacturing, as well as insights into clinical development strategy, which are pivotal in achieving successful market entry. By attending the event, participants will learn how to formulate poorly soluble and poorly permeable drugs safely and effectively, streamline manufacturing processes to reduce costs, implement efficient clinical trials, and develop early commercial plans that maximize the chances of market success. Additionally, attendees will have the opportunity to tour the Catalent Nottingham facility, where they will see firsthand how Catalent can help them translate formulation advances into clinical success.

Are you looking for a solution for your drug development challenges?

Catalent have limited slots available for a complimentary consultation with their seasoned speakers after the tour. Do not miss out on this opportunity to gain valuable insights, secure your free spot today.


  • 10:00 Registration & Networking

  • 10:40 Welcome Note & Introduction

    Matthew Streeter General Manager, Catalent 

  • 11:00 Why, When and How to Apply Bioavailability Enhancing Technologies in Early-Phase Drug Development

    Stephen Tindal, Director, Science & Technology, Catalent

  • 11:30 Roadmap to Early Clinical Entry (The Devil is in the Detail)

    Katsuhiro Mihara, Head of Clinical Development & PK/PD, Venn Life Sciences

  • 12:00 Networking Lunch

  • 13:00 Clinical Development Hurdles - A Consultant's Perspective on Infrastructure Pitfalls

    Mark Saunders, Director and Founder, P2C Pharma

  • 13:30 Navigating the Path to Drug Development: Overcoming Challenges and Leveraging CDMO Expertise

    Industry expert - TBC

  • 13:45 Panel Discussion

    Moderated by: Matt Ling, Director of Scientific Services, Catalent 

    Mark Saunders, Director and Founder,P2C Pharma

    Katsuhiro Mihara, Head of Clinical Development & PK/PD,Venn Life Sciences

    Stephen Tindal, Director, Science & Technology, Catalent

    Matthew Streeter, General Manager, Catalent 

  • 14:15 Break and prepare for site tour

  • 16:30 Closing Remarks

Venue Information

DoubleTree by Hilton Nottingham - Gateway, Nuthall Rd, Nottingham NG8 6AZ

The DoubleTree by Hilton Nottingham - Gateway is a mille of the M1 motorway and a 2-minute walk from Cinderhill tram stop with links to Nottingham city center, three miles away.


There is 200 free onsite car parking spaces.